INS and cystic fibrosis: Several factors including chronic or recurrent respiratory infections, corticosteroid therapy, subclinical liver fibrosis, elevated serum levels of counter regulatory hormones, increased proinflammatory cytokines, and glycotoxicity could impact insulin sensitivity in patients with CF [3,40].